NEW YORK (GenomeWeb) – Roche today announced that the Global Fund has selected the company as a supplier of early infant and viral load HIV diagnostics.

Roche will supply two tests, both of which use a dual-target design to amplify and detect two regions of the HIV-1 genome not subject to selective drug pressure, the firm said in a statement.

The cobas AmpliPrep/cobas TaqMan HIV-1 Test v2.0 detects group M and O strains of HIV-1 and has a broad dynamic range for viral load monitoring. The test runs on the firm's fully automated real-time PCR platform.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.

Sponsored by

This webinar will discuss a new approach to amplicon sequencing that addresses the current inefficiencies of the method, such as small designs, primer drop outs, and low uniformity.

Sponsored by

This webinar will discuss how acoustic liquid handling can reduce the time and costs for labs performing carrier screening with next-generation sequencing.

Sponsored by
Horizon Discovery

This webinar will provide an in-depth case study demonstrating how reference standards can be used to develop and validate circulating tumor DNA (ctDNA)-based assays.

Sponsored by

This webinar will discuss how an algorithm-driven synthetic biology system can enable engineering of biological systems for a range of applications.